During the past ten years, a number of original publications, reviews and metaanalyses were published on the cardiovascular (CV) safety of nonsteroidal antiinflammatory drugs (NSAIDs). These data were summarised in several previous publications. As this group of medicines is very frequently used and many of thern are available over the counter (OTC), their risks require particular attention. Recently, new analyses have been published on previously discussed preparations as well as on new drugs that had been omitted from previous analyses (paracetamol, aceclofenac), thus, it is important to review these data and draw attention again to differences in side effects among NSAIDs.
|Translated title of the contribution||The risk of nonsteroidal antiinflammatory drugs|
|Number of pages||6|
|Journal||Lege Artis Medicinae|
|Publication status||Published - Feb 1 2012|
ASJC Scopus subject areas